Salcaprozate sodium

Salcaprozate sodium (SNAC), an oral absorption promoter, and has the potential as a delivery agent for oral forms of heparin and insulin. Salcaprozate sodium could increase passive transcellular permeation across small intestinal epithelia based on increased lipophilicity arising from non-covalent macromolecule complexation.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Salcaprozate sodium(CAS 203787-91-1)

CAT No: R1937

CAS No:203787-91-1

Synonyms/Alias:Salcaprozate sodium;203787-91-1;sodium 8-(2-hydroxybenzamido)octanoate;SNAC;Salcaprozate sodium [USAN];sodium 8-[(2-hydroxybenzoyl)amino]octanoate;Sodium salcaprozate;sodium;8-[(2-hydroxybenzoyl)amino]octanoate;E414;Octanoic acid, 8-[(2-hydroxybenzoyl)amino]-, monosodium salt;UNII-1YTW0422YU;Salcaprozic acid, sodium salt;1YTW0422YU;Salcaprozate (sodium);MFCD00952954;Salcaprozate sodium (USAN);E 414;E-414;Sodium 8-((2-hydroxybenzoyl)amino)octanoate;DTXSID50174306;sodium,8-[(2-hydroxybenzoyl)amino]octanoate;Octanoic acid, 8-((2-hydroxybenzoyl)amino)-, monosodium salt;Salcaprozic acid sodium salt;P414;C15H20NNaO4;Octanoic acid, 8-[(2-hydroxybenzoyl)amino]-, sodium salt;SNAC sodium;SCHEMBL825599;CHEMBL2107027;DTXCID3096797;Salcaprozate (sodium) (Standard);UOENJXXSKABLJL-UHFFFAOYSA-M;EX-A3434;Sodium 8-(salicyloylamino)octanoate;sodium8-(2-hydroxybenzamido)octanoate;AKOS027252576;HY-114299R;AC-31357;AS-65676;DA-67382;FS168567;SY111977;HY-114299;CS-0081977;D05787;I10998;Q27253228;SODIUM 8-[(2-HYDROXYPHENYL)FORMAMIDO]OCTANOATE;807-387-2;

Chemical Name:sodium;8-[(2-hydroxybenzoyl)amino]octanoate

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C15H20NNaO4
M.W/Mr.
301.31
Application
Delivery agent
Long-term Storage Conditions
10 mM in DMSO
InChI
InChI=1S/C15H21NO4.Na/c17-13-9-6-5-8-12(13)15(20)16-11-7-3-1-2-4-10-14(18)19;/h5-6,8-9,17H,1-4,7,10-11H2,(H,16,20)(H,18,19);/q;+1/p-1
InChI Key
UOENJXXSKABLJL-UHFFFAOYSA-M
Canonical SMILES
C1=CC=C(C(=C1)C(=O)NCCCCCCCC(=O)[O-])O.[Na+]
References
1. Riley MGI, et, al. Subchronic oral toxicity of salcaprozate sodium (SNAC) in Sprague-Dawley and Wistar rats. Int J Toxicol. Jul-Aug 2009; 28(4):278-93.
2. Twarog C, et, al. Intestinal Permeation Enhancers for Oral Delivery of Macromolecules: A Comparison between Salcaprozate Sodium (SNAC) and Sodium Caprate (C 10). Pharmaceutics. 2019 Feb 13; 11(2):78.
3. Li Y, et, al. Impact of Sodium N-[8-(2-Hydroxybenzoyl)amino]-caprylate on Intestinal Permeability for Notoginsenoside R1 and Salvianolic Acids in Caco-2 Cells Transport and Rat Pharmacokinetics. Molecules. 2018 Nov 16; 23(11):2990.

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Modification ServicescGMP Peptide ServiceEpitope Mapping ServicesPeptide Analysis ServicesPeptide CDMOPeptide Nucleic Acids SynthesisCustom Conjugation ServicePeptide Synthesis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers